Title

Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger
Ultrasound-Guided Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger: Randomized Controlled Study
  • Phase

    Early Phase 1
  • Study Type

    Interventional
  • Status

    Unknown status
  • Study Participants

    100
The aim of the study is to compare the therapeutic effects of hyaluronic acid versus steroid injections in treating trigger fingers using ultrasound guidance
A prospective randomized controlled study designed to compare the outcomes of injecting patients with trigger finger with hyaluronic acid versus corticosteroid under ultrasound guidance
Study Started
Nov 06
2020
Primary Completion
Apr 05
2021
Anticipated
Study Completion
Jun 04
2021
Anticipated
Last Update
Nov 27
2020

Drug hyaluronic acid (20 mg/2 mL)

A1-Pulley infiltration for trigger finger

  • Other names: Hyalgan 20 mg in 2 ML Prefilled Syringe

Drug Triamcinolone acetonide 10mg/ml

A1-Pulley infiltration for trigger finger

  • Other names: Kenalog 10 mg/ml

Hyaluronic acid Experimental

1mL of hyaluronic acid (20 mg/2 mL; Hyalgan, Fidia, Abano Terme, Italy) infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1-pulley.

Triamcinolone acetonide Active Comparator

1 mL of Triamcinolone acetonide 10mg/ml infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1 pulley.

Criteria

Inclusion Criteria:

Adult (>18 years)
Patients with a clinical diagnosis of trigger finger grade 1-3 on the Quinnell grading scale and confirmed diagnosis by ultrasound.

Exclusion Criteria:

Quinnell's classification grade IV (contracture)
Prior injection within 6 months
Prior operation of the affected finger
Presence of any contracture in the proximal interphalangeal or metacarpophalangeal joint, and
History of diabetes, hypothyroidism, and
Rheumatic or connective tissue disease
Allergy to triamcinolone or hyaluronic acid
Pregnancy
Secondary triggering e.g. Trauma, infection
Trigger finger symptoms duration >6 months
No Results Posted